Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
River Eletec
6666
Forside
2330
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | |
---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||
Cash from operating activities | -37.45%359.46M | 1,495.18%574.63M | -77.30%36.02M | -45.55%158.7M | 94.59%291.49M | -35.63%149.8M | 37.98%232.7M | 168.65M |
Net profit before non-cash adjustment | 5.58%292.2M | 105.67%276.74M | 84.56%134.56M | -60.39%72.91M | -6.83%184.08M | 51.39%197.57M | 5.78%130.5M | --123.38M |
Total adjustment of non-cash items | -16.86%325.87M | 234.90%391.96M | 464.42%117.04M | -130.14%-32.12M | 2,733.56%106.55M | -103.53%-4.05M | 117.39%114.56M | --52.7M |
-Depreciation and amortization | 11.12%339.06M | 43.51%305.11M | 77.12%212.6M | 15.50%120.03M | 28.86%103.93M | 3.52%80.65M | 21.94%77.91M | --63.89M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | 8,291.68%65.54M | --781K | ---- | ---- | ---- |
-Disposal profit | --0 | --0 | --0 | -88.18%402K | 309.76%3.4M | 32.17%830K | 685.00%628K | --80K |
-Net exchange gains and losses | -102.18%-269K | -7.98%12.32M | 982.79%13.39M | 72.37%-1.52M | -233.80%-5.49M | -637.67%-1.65M | -104.58%-223K | --4.87M |
-Deferred income tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --9.09M |
-Other non-cash items | -117.33%-12.92M | 168.39%74.52M | 49.69%-108.96M | -5,605.16%-216.57M | 104.69%3.93M | -331.42%-83.88M | 243.71%36.25M | ---25.22M |
Changes in working capital | -174.90%-258.61M | 56.36%-94.07M | -282.83%-215.57M | 13,674.42%117.91M | 101.96%856K | -253.68%-43.72M | -66.33%-12.36M | ---7.43M |
-Change in receivables | 190.86%110.47M | -241.89%-121.58M | 807.20%85.69M | 136.74%9.45M | 50.89%-25.71M | -220.46%-52.34M | -181.14%-16.33M | --20.13M |
-Change in inventory | -627.29%-392.74M | 74.04%-54M | -1,297.11%-208M | -135.83%-14.89M | 232.21%41.55M | -460.48%-31.43M | -575.98%-5.61M | --1.18M |
-Change in payables | -72.58%21.58M | 176.48%78.71M | -184.26%-102.91M | 619.50%122.13M | -166.43%-23.51M | 476.78%35.39M | 116.40%6.14M | ---37.41M |
-Provision for loans, leases and other losses | -25.77%2.08M | -71.01%2.8M | 692.36%9.65M | -85.71%1.22M | 83.19%8.52M | 35.18%4.65M | -60.32%3.44M | --8.67M |
Dividends paid (cash flow from operating activities) | ||||||||
Dividends received (cash flow from operating activities) | ||||||||
Interest paid (cash flow from operating activities) | -76.33%-57.3M | -3.70%-32.49M | -87.38%-31.34M | 3.49%-16.72M | -28.25%-17.33M | 6.58%-13.51M | -0.40%-14.46M | -14.4M |
Interest received (cash flow from operating activities) | 465.07%7.44M | 69.72%1.32M | -3.84%776K | -28.20%807K | -66.94%1.12M | 220.45%3.4M | 1,557.81%1.06M | 64K |
Tax refund paid | -184.51%-67.07M | -68.95%-23.58M | -688.36%-13.95M | 95.06%-1.77M | -3.71%-35.8M | 10.75%-34.52M | -1,001.37%-38.68M | -3.51M |
Other operating cash inflow (outflow) | 0.00%-1K | -200.00%-1K | 1K | 0 | 1K | 0 | -1K | 0 |
Operating cash flow | -53.35%242.53M | 6,224.13%519.88M | -106.02%-8.49M | -41.12%141.02M | 127.72%239.49M | -41.77%105.17M | 19.78%180.62M | --150.79M |
Investing cash flow | ||||||||
Net PPE purchase and sale | -35.24%-374.95M | 11.22%-277.24M | -4.68%-312.3M | -12.97%-298.32M | -329.69%-264.07M | 20.28%-61.46M | -56.76%-77.09M | ---49.18M |
Net intangibles purchase and sale | -50.28%-10.35M | 43.58%-6.89M | ---12.21M | --0 | ---6.73M | ---- | ---847K | ---- |
Net business purchase and sale | ---- | ---- | ---- | ---541.56M | ---- | ---- | ---- | ---- |
Net investment product transactions | --0 | -147.75%-74.32M | ---30M | --0 | ---- | ---- | -752.91%-22.2M | --3.4M |
Net changes in other investments | -97.00%3.75M | 12,644.54%125.32M | 98.04%-999K | 0.96%-51.03M | -590.45%-51.53M | 643.79%10.51M | ---1.93M | ---- |
Investing cash flow | -63.66%-381.55M | 34.42%-233.14M | 60.10%-355.51M | -176.40%-890.91M | -532.62%-322.32M | 50.08%-50.95M | -122.97%-102.07M | ---45.78M |
Financing cash flow | ||||||||
Net issuance payments of debt | 108.55%274.27M | 182.32%131.51M | -112.75%-159.76M | 730.97%1.25B | 1,036.31%150.75M | -121.19%-16.1M | 32.22%75.97M | --57.46M |
Net common stock issuance | ---- | ---- | ---36.4M | --0 | ---- | ---- | ---- | ---- |
Cash dividends paid | -66.67%-20.68M | 1.34%-12.41M | 0.00%-12.58M | ---12.58M | ---- | ---- | ---- | ---- |
Net other fund-raising expenses | -36.64%-46.33M | -279.89%-33.91M | ---8.93M | ---- | ---1K | ---- | ---- | ---1K |
Financing cash flow | 143.27%207.26M | 139.14%85.2M | -117.55%-217.66M | 722.63%1.24B | 1,036.30%150.75M | -121.19%-16.1M | 32.22%75.97M | --57.45M |
Net cash flow | ||||||||
Beginning cash position | 82.79%900.02M | -53.48%492.38M | 88.75%1.06B | 15.66%560.74M | 9.52%484.8M | 52.08%442.66M | 126.35%291.06M | --128.59M |
Current changes in cash | -81.65%68.24M | 163.94%371.94M | -218.66%-581.65M | 621.85%490.18M | 78.16%67.91M | -75.33%38.12M | -4.90%154.52M | --162.47M |
Effect of exchange rate changes | -21.88%27.9M | 128.60%35.71M | 108.42%15.62M | -6.67%7.5M | 99.28%8.03M | 237.97%4.03M | ---2.92M | ---- |
Cash adjustments other than cash changes | --2K | ---- | ---2K | ---- | --1K | ---- | ---- | --2K |
End cash Position | 10.68%996.16M | 82.79%900.02M | -53.48%492.38M | 88.75%1.06B | 15.66%560.74M | 9.52%484.8M | 52.08%442.66M | --291.06M |
Free cash flow | -160.56%-142.77M | 170.79%235.75M | -111.69%-333M | -402.39%-157.31M | -175.45%-31.31M | -55.40%41.5M | -7.59%93.05M | --100.7M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |